Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

3 Reasons to Pump the Brakes on ElectraMeccanica Vehicles

ElectroMeccanica Vehicles is launching a single-seat vehicle. It may be the next new thing, but before you buy SOLO stock here are three things to consider.

As Optimism Wanes, the Ride May Be Over for Novavax stock

Novavax has been one of the companies cashing in on the race to find a vaccine against COVID-19. As a result NVAX stock is up over 3,000% year-to-date

Investors Should Take a Vacation From Delta Stock

DAL stock is down more than 25% in the last month. With no revenue catalyst in the near future, it may be wise for investors to stay away.

It Will Be a Long, Long Time Before Carnival Stock Is Worth Owning Again

Management deserves a lot of credit in keeping CCL stock healthy, but Covid-19 and high debt are destroying the chances of a quick recovery.

4 Travel Stocks Still Not Ready for R&R

Some travel stocks will have long-term upside when and if normalcy returns. But for these four names, too many challenges remain.

Until Management Offers a Clear Path to Profitability, Avoid FCEL Stock

Despite FuelCell stock's recent success, lack of revenue creates a great deal of uncertainty for FCEL stock

7 Bank Stocks That Are Struggling to Escape Precarious Situations

The banking sector is having a good Q2 earnings season. But the coast isn't clear for all banks yet. Avoid these bank stocks.

Systemic Issues Will Continue to Jolt General Electric

In my previous article, I mentioned how General Electric (NYSE:GE) stock is a bad investment and will continue to be so for the foreseeable future.…

As ‘EV Fever’ Cools Down, Avoid Plug Power Stock

With upside priced-in, it doesn't look worthwhile buying PLUG stock at today's prices. And, with red flags abound, there's plenty of reason why shares could tumble back to prior price levels.

Be Careful With Twitter Stock

Twitter and its ads don't mix well. In the absence of supercharged revenue growth, TWTR stock looks overvalued.

American Airlines Stock Will Remain Turbulent for Awhile

American Airlines is doing everything it can to survive, but its capacity outlook is a warning sign for those considering buying AAL stock.

The Best of the 2020 Rally in Chipotle Stock Has Already Happened

Chipotle is a winner, but the CMG stock price already fully reflects this reality, and further upside potential in 2020 seems limited.

Sadly for Genius Brands, Where There’s Smoke, There’s Fire

Scott+Scott Attorneys at Law LLP are investigating possible misleading statements by Genius Brands (NASDAQ:GNUS). Should you sell GNUS stock?  

The Trouble With Luckin Stock Goes Way Beyond Accounting Fraud

While Luckin stock has the potential to deliver a massive recovery in the months to come, there are too many unknowns to make it a sound choice right now.

4 Reasons to Sell Delisted and Distressed Luckin Stock

Luckin stock went from being seen as a very real competitor to Starbucks, to losing over 90% of its value in just a few months. Its troubles are not yet past.

Why You Should Continue to Avoid General Electric Stock

General Electric continues to lag its peers, sector and the overall market. There's no reason to dive into GE stock amid this lag.

Luckin Coffee’s Hopes for a Recovery Got Trumped

At first glance, the deep discount in Luckin stock might tempt some gamblers. However, the fundamental case for Luckin Coffee took a major hit with worsening U.S.-China relations.

The Further It Lags in the Vaccine Race, the Riskier Inovio Stock Looks

Inovio Pharmaceuticals (NASDAQ:INO) is a contender in the hyper-competitive field to develop a novel coronavirus vaccine, but with the company falling behind rivals, INO stock…

Sorrento Therapeutics May Be Ready For a Pullback

Extreme volatility is name of the game with shares of small biotech companies such as Sorrento Therapeutics. Investors should be ready to embrace further choppiness in the coming weeks.